Total votes: 3

Cryosite’s principal activities include:

 - private collection and storage of umbilical cord blood stem cells
 - distribution of temperature-critical biological products
 - clinical trial logistics services
 -  biorepository management services

The Company provides specialized services to a range of clients, including medical research, pharmaceutical and biotechnology industries. The Company is the distributor of products from the American Type Culture Collection. It has customer base of over 400 research institutions and biotechnology companies in Australia and New Zealand. The Company’s services include cord blood, clinical trial services, archival, cryobyte and adult stem cell storage.

Net profit for Cryosite was down 98.4%, from $447,059 to $7,249, in the year to 30 June 2009.

Revenue in the year to 30 June 2009 was down 5.5% to $6.3 million.

Cash reserves were down 32.8% to $1.3 million in the year to 30 June 2009.